[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100543928":3},{"organization":4,"armGroups":7,"interventions":40,"overallOfficials":55,"centralContacts":59,"locations":69,"responsibleParty":666,"collaborators":668,"id":671,"slug":51,"hasResults":672,"nctId":673,"briefTitle":674,"officialTitle":675,"acronym":51,"eligibilityCriteria":676,"healthyVolunteers":672,"sex":677,"minAge":678,"maxAge":51,"enrollmentInfo":679,"targetDuration":51,"studyType":682,"phases":683,"briefSummary":686,"conditions":687,"keywords":689,"overallStatus":72,"whyStopped":51,"lastUpdateSubmitDate":691,"lastUpdatePostDateStruct":692,"startDateStruct":695,"completionDateStruct":697,"leadSponsor":699,"locationsCount":700},{"fullName":5,"class":6},"Daiichi Sankyo","INDUSTRY",[8,15,20,24,28,32,36],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort 1, Part A: Maintenance Only (I-DXd 12 mg\u002Fkg)","EXPERIMENTAL","Part A (Safety Run-in): Participants who must have received 4 cycles of 1L induction standard of care (SoC) therapy with best overall response of CR, PR, or SD will receive maintenance therapy only. Maintenance therapy consisting of I-DXd 12 mg\u002Fkg (or a lower dose based on data for I-DXd collected during the study) + atezolizumab 1200 mg IV Q3W.\n\nA 5-day surveillance period between each of the first 3 participants (up to a maximum of 9 participants) dosed is included as a safety measure.",[13,14],"Drug: Ifinatamab deruxtecan","Drug: Atezolizumab",{"label":16,"type":10,"description":17,"interventionNames":18},"Cohort 2, Part A: Induction + Maintenance (I-DXd 8 mg\u002Fkg)","Part A (Safety Run-in): Participants who are treatment-naive, newly diagnosed with ES-SCLC will receive 4 cycles of 1L I-DXd induction therapy (8 mg\u002Fkg IV Q3W) + atezolizumab (1200 mg IV Q3W) + carboplatin (AUC 5 mg\u002Fml×min IV Q3W) followed by maintenance therapy. Maintenance therapy consisting of I-DXd 8 mg\u002Fkg (or a lower dose based on data for I-DXd collected during the study) + atezolizumab 1200 mg IV Q3W.",[13,14,19],"Drug: Carboplatin",{"label":21,"type":10,"description":22,"interventionNames":23},"Cohort 2, Part A: Induction + Maintenance (I-DXd 12 mg\u002Fkg)","Part A (Safety Run-in): Participants who are treatment-naive, newly diagnosed with ES-SCLC will receive 4 cycles of 1L I-DXd induction therapy (12 mg\u002Fkg IV Q3W) + atezolizumab (1200 mg IV Q3W) + carboplatin (AUC 5 mg\u002Fml×min IV Q3W) followed by maintenance therapy. Maintenance therapy consisting of I-DXd 12 mg\u002Fkg (or a lower dose based on data for I-DXd collected during the study) + atezolizumab 1200 mg IV Q3W.",[13,14,19],{"label":25,"type":10,"description":26,"interventionNames":27},"Cohort 1, Part B: Maintenance (I-DXd 8 mg\u002Fkg)","Part B: Participants who must have received 4 cycles of 1L induction standard of care (SoC) therapy with best overall response of CR, PR, or SD will receive maintenance therapy only starting at Cycle 1 Day 1. Maintenance therapy consisting of I-DXd 8 mg\u002Fkg (or a lower dose based on data for I-DXd collected during the study) + atezolizumab 1200 mg IV Q3W",[13,14],{"label":29,"type":10,"description":30,"interventionNames":31},"Cohort 1, Part B: Maintenance (I-DXd 12 mg\u002Fkg)","Part B: Participants who must have received 4 cycles of 1L induction standard of care (SoC) therapy with best overall response of CR, PR, or SD will receive maintenance therapy only starting at Cycle 1 Day 1. Maintenance therapy consisting of I-DXd 12 mg\u002Fkg (or a lower dose based on data for I-DXd collected during the study) + atezolizumab 1200 mg IV Q3W.",[13,14],{"label":33,"type":10,"description":34,"interventionNames":35},"Cohort 2, Part B: Induction + Maintenance (I-DXd 8 mg\u002Fkg)","Participants who are treatment-naive, newly diagnosed with ES-SCLC will receive 4 cycles of 1L I-DXd induction therapy (8 mg\u002Fkg IV Q3W) + atezolizumab (1200 mg IV Q3W) + carboplatin (AUC 5 mg\u002Fml×min IV Q3W) followed by maintenance therapy. Maintenance therapy consisting of I-DXd 8 mg\u002Fkg (or a lower dose based on data for I-DXd collected during the study) + atezolizumab 1200 mg IV Q3W.",[13,14,19],{"label":37,"type":10,"description":38,"interventionNames":39},"Cohort 2, Part B: Induction + Maintenance (I-DXd 12 mg\u002Fkg)","Participants who are treatment-naive, newly diagnosed with ES-SCLC will receive 4 cycles of IL I-DXd induction therapy (12 mg\u002Fkg IV Q3W) + atezolizumab (1200 mg IV Q3W) + carboplatin (AUC 5 mg\u002Fml×minIV Q3W) followed by maintenance therapy. Maintenance therapy consisting of I-DXd 12 mg\u002Fkg (or a lower dose based on data for I-DXd collected during the study) + atezolizumab 1200 mg IV Q3W.",[13,14,19],[41,48,52],{"type":42,"name":43,"description":44,"armGroupLabels":45,"otherNames":46},"DRUG","Ifinatamab deruxtecan","Intravenous administration",[9,29,25,21,16,37,33],[47],"I-DXd",{"type":42,"name":49,"description":44,"armGroupLabels":50,"otherNames":51},"Atezolizumab",[9,29,25,21,16,37,33],null,{"type":42,"name":53,"description":44,"armGroupLabels":54,"otherNames":51},"Carboplatin",[21,16,37,33],[56],{"name":57,"affiliation":5,"role":58},"Global Clinical Leader","STUDY_DIRECTOR",[60,65],{"name":61,"role":62,"phone":63,"phoneExt":51,"email":64},"(US) Daiichi Sankyo Contact for Clinical Trial Information","CONTACT","9089926400","CTRinfo_us@daiichisankyo.com",{"name":66,"role":62,"phone":67,"phoneExt":51,"email":68},"(Asia) Daiichi Sankyo Contact for Clinical Trial Information","+81-3-6225-1111 (M-F 9-5 JST","dsclinicaltrial@daiichisankyo.co.jp",[70,87,99,112,123,135,146,155,167,178,190,201,213,223,234,246,253,263,271,277,287,296,304,316,328,340,352,365,376,387,398,406,417,428,439,450,456,462,473,484,495,501,512,523,534,543,547,560,568,579,590,601,609,617,625,636,647,655],{"facility":71,"status":72,"city":73,"state":74,"zip":75,"country":76,"countryCode":77,"cosmosGeoPoint":78,"geoPoint":83,"contacts":84},"University of Alabama -Birmingham","RECRUITING","Birmingham","Alabama","35233","United States","US",{"type":79,"coordinates":80},"Point",[81,82],-86.80249,33.52066,{"lat":82,"lon":81},[85],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},"Principal Investigator",{"facility":88,"status":72,"city":89,"state":90,"zip":91,"country":76,"countryCode":77,"cosmosGeoPoint":92,"geoPoint":96,"contacts":97},"Mayo Clinic Arizona","Phoenix","Arizona","85054",{"type":79,"coordinates":93},[94,95],-112.07404,33.44838,{"lat":95,"lon":94},[98],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":100,"status":101,"city":102,"state":103,"zip":104,"country":76,"countryCode":77,"cosmosGeoPoint":105,"geoPoint":109,"contacts":110},"David Geffen School of Medicine","NOT_YET_RECRUITING","Los Angeles","California","90095",{"type":79,"coordinates":106},[107,108],-118.24368,34.05223,{"lat":108,"lon":107},[111],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":113,"status":72,"city":114,"state":103,"zip":115,"country":76,"countryCode":77,"cosmosGeoPoint":116,"geoPoint":120,"contacts":121},"Hoag Memorial Hospital Presbyterian","Newport Beach","92663",{"type":79,"coordinates":117},[118,119],-117.92895,33.61891,{"lat":119,"lon":118},[122],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":124,"status":72,"city":125,"state":126,"zip":127,"country":76,"countryCode":77,"cosmosGeoPoint":128,"geoPoint":132,"contacts":133},"Mayo Clinic-Jacksonville","Jacksonville","Florida","32224",{"type":79,"coordinates":129},[130,131],-81.65565,30.33218,{"lat":131,"lon":130},[134],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":136,"status":72,"city":137,"state":126,"zip":138,"country":76,"countryCode":77,"cosmosGeoPoint":139,"geoPoint":143,"contacts":144},"Advent Health Orlando","Orlando","32804",{"type":79,"coordinates":140},[141,142],-81.37924,28.53834,{"lat":142,"lon":141},[145],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":147,"status":72,"city":148,"state":126,"zip":149,"country":76,"countryCode":77,"cosmosGeoPoint":150,"geoPoint":154,"contacts":51},"Moffitt Cancer Center","Tampa","33612",{"type":79,"coordinates":151},[152,153],-82.45843,27.94752,{"lat":153,"lon":152},{"facility":156,"status":72,"city":157,"state":158,"zip":159,"country":76,"countryCode":77,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","Chicago","Illinois","60611",{"type":79,"coordinates":161},[162,163],-87.65005,41.85003,{"lat":163,"lon":162},[166],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":168,"status":169,"city":170,"state":171,"zip":172,"country":76,"countryCode":77,"cosmosGeoPoint":173,"geoPoint":177,"contacts":51},"Henry Ford Hospital","ACTIVE_NOT_RECRUITING","Detroit","Michigan","48202",{"type":79,"coordinates":174},[175,176],-83.04575,42.33143,{"lat":176,"lon":175},{"facility":179,"status":72,"city":180,"state":181,"zip":182,"country":76,"countryCode":77,"cosmosGeoPoint":183,"geoPoint":187,"contacts":188},"Regents of the University of Minnesota","Minneapolis","Minnesota","55455",{"type":79,"coordinates":184},[185,186],-93.26384,44.97997,{"lat":186,"lon":185},[189],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":191,"status":72,"city":192,"state":181,"zip":193,"country":76,"countryCode":77,"cosmosGeoPoint":194,"geoPoint":198,"contacts":199},"Mayo Clinic","Rochester","55905",{"type":79,"coordinates":195},[196,197],-92.4699,44.02163,{"lat":197,"lon":196},[200],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":202,"status":72,"city":203,"state":204,"zip":205,"country":76,"countryCode":77,"cosmosGeoPoint":206,"geoPoint":210,"contacts":211},"Dartmouth-Hitchcock Medical Center","Lebanon","New Hampshire","03766",{"type":79,"coordinates":207},[208,209],-72.25176,43.64229,{"lat":209,"lon":208},[212],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":214,"status":72,"city":215,"state":216,"zip":217,"country":76,"countryCode":77,"cosmosGeoPoint":218,"geoPoint":222,"contacts":51},"Astera Cancer Care","East Brunswick","New Jersey","08816",{"type":79,"coordinates":219},[220,221],-74.41598,40.42788,{"lat":221,"lon":220},{"facility":224,"status":72,"city":225,"state":216,"zip":226,"country":76,"countryCode":77,"cosmosGeoPoint":227,"geoPoint":231,"contacts":232},"John Theurer Cancer Center At Hackensack Umc","Hackensack","07601",{"type":79,"coordinates":228},[229,230],-74.04347,40.88593,{"lat":230,"lon":229},[233],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":235,"status":72,"city":236,"state":237,"zip":238,"country":76,"countryCode":77,"cosmosGeoPoint":239,"geoPoint":243,"contacts":244},"New York University Cancer Center - Laura and Isaac Perlmutter Cancer Center At Nyu Langone","Mineola","New York","11501",{"type":79,"coordinates":240},[241,242],-73.64068,40.74927,{"lat":242,"lon":241},[245],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":247,"status":72,"city":236,"state":237,"zip":238,"country":76,"countryCode":77,"cosmosGeoPoint":248,"geoPoint":250,"contacts":251},"NYU Langone Hospital - Long Island",{"type":79,"coordinates":249},[241,242],{"lat":242,"lon":241},[252],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":254,"status":72,"city":237,"state":237,"zip":255,"country":76,"countryCode":77,"cosmosGeoPoint":256,"geoPoint":260,"contacts":261},"Memorial Sloan Kettering Cancer Center","10021",{"type":79,"coordinates":257},[258,259],-74.00597,40.71427,{"lat":259,"lon":258},[262],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":264,"status":72,"city":237,"state":237,"zip":265,"country":76,"countryCode":77,"cosmosGeoPoint":266,"geoPoint":268,"contacts":269},"Columbia University Hervert Irving Comprehensive Cancer Center","10032",{"type":79,"coordinates":267},[258,259],{"lat":259,"lon":258},[270],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":272,"status":72,"city":237,"state":237,"zip":273,"country":76,"countryCode":77,"cosmosGeoPoint":274,"geoPoint":276,"contacts":51},"Montefiore Medical Center","10461",{"type":79,"coordinates":275},[258,259],{"lat":259,"lon":258},{"facility":278,"status":72,"city":279,"state":280,"zip":281,"country":76,"countryCode":77,"cosmosGeoPoint":282,"geoPoint":286,"contacts":51},"Lancaster General Hospital - Ann B Barshinger Cancer Institute","Lancaster","Pennsylvania","17601",{"type":79,"coordinates":283},[284,285],-76.30551,40.03788,{"lat":285,"lon":284},{"facility":288,"status":72,"city":289,"state":280,"zip":290,"country":76,"countryCode":77,"cosmosGeoPoint":291,"geoPoint":295,"contacts":51},"University of Pennsylvania, Abramson Cancer Center","Philadelphia","19104",{"type":79,"coordinates":292},[293,294],-75.16362,39.95238,{"lat":294,"lon":293},{"facility":297,"status":72,"city":289,"state":280,"zip":298,"country":76,"countryCode":77,"cosmosGeoPoint":299,"geoPoint":301,"contacts":302},"Thomas Jefferson University Hospital - Central","19107",{"type":79,"coordinates":300},[293,294],{"lat":294,"lon":293},[303],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":305,"status":72,"city":306,"state":307,"zip":308,"country":76,"countryCode":77,"cosmosGeoPoint":309,"geoPoint":313,"contacts":314},"Scri Oncology Partners","Nashville","Tennessee","37203",{"type":79,"coordinates":310},[311,312],-86.78444,36.16589,{"lat":312,"lon":311},[315],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":317,"status":72,"city":318,"state":319,"zip":320,"country":76,"countryCode":77,"cosmosGeoPoint":321,"geoPoint":325,"contacts":326},"Next Virginia","Fairfax","Virginia","22031",{"type":79,"coordinates":322},[323,324],-77.30637,38.84622,{"lat":324,"lon":323},[327],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":329,"status":72,"city":330,"state":331,"zip":332,"country":76,"countryCode":77,"cosmosGeoPoint":333,"geoPoint":337,"contacts":338},"Northwest Cancer Specialists, P.C.-Vancouver","Vancouver","Washington","98684",{"type":79,"coordinates":334},[335,336],-122.66149,45.63873,{"lat":336,"lon":335},[339],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":341,"status":72,"city":342,"state":343,"zip":344,"country":76,"countryCode":77,"cosmosGeoPoint":345,"geoPoint":349,"contacts":350},"Medical College of Wisconsin","Milwaukee","Wisconsin","53226",{"type":79,"coordinates":346},[347,348],-87.90647,43.0389,{"lat":348,"lon":347},[351],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":353,"status":72,"city":354,"state":51,"zip":355,"country":356,"countryCode":357,"cosmosGeoPoint":358,"geoPoint":362,"contacts":363},"Hopital Albert Calmette - Chu Lille","Lille","59037","France","FR",{"type":79,"coordinates":359},[360,361],3.05512,50.63391,{"lat":361,"lon":360},[364],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":366,"status":72,"city":367,"state":51,"zip":368,"country":356,"countryCode":357,"cosmosGeoPoint":369,"geoPoint":373,"contacts":374},"Centre Léon Bérard","Lyon","69008",{"type":79,"coordinates":370},[371,372],4.84789,45.74906,{"lat":372,"lon":371},[375],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":377,"status":72,"city":378,"state":51,"zip":379,"country":356,"countryCode":357,"cosmosGeoPoint":380,"geoPoint":384,"contacts":385},"Hôpital de la Timone","Marseille","13005",{"type":79,"coordinates":381},[382,383],5.38107,43.29695,{"lat":383,"lon":382},[386],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":388,"status":72,"city":389,"state":51,"zip":390,"country":356,"countryCode":357,"cosmosGeoPoint":391,"geoPoint":395,"contacts":396},"Institut Curie - Site de Paris","Paris","75005",{"type":79,"coordinates":392},[393,394],2.3488,48.85341,{"lat":394,"lon":393},[397],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":399,"status":72,"city":389,"state":51,"zip":400,"country":356,"countryCode":357,"cosmosGeoPoint":401,"geoPoint":403,"contacts":404},"Hopital Tenon","75020",{"type":79,"coordinates":402},[393,394],{"lat":394,"lon":393},[405],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":407,"status":72,"city":408,"state":51,"zip":409,"country":356,"countryCode":357,"cosmosGeoPoint":410,"geoPoint":414,"contacts":415},"Chu Rennes - Hopital Pontchaillou","Rennes","35000",{"type":79,"coordinates":411},[412,413],-1.67431,48.11109,{"lat":413,"lon":412},[416],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":418,"status":72,"city":419,"state":51,"zip":420,"country":356,"countryCode":357,"cosmosGeoPoint":421,"geoPoint":425,"contacts":426},"CHU Nantes - Hôpital Guillaume et René Laënnec","Saint-Herblain","44805",{"type":79,"coordinates":422},[423,424],-1.651,47.21154,{"lat":424,"lon":423},[427],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":429,"status":72,"city":430,"state":51,"zip":431,"country":356,"countryCode":357,"cosmosGeoPoint":432,"geoPoint":436,"contacts":437},"Hôpital Foch","Suresnes","92151",{"type":79,"coordinates":433},[434,435],2.22929,48.87143,{"lat":435,"lon":434},[438],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":440,"status":101,"city":441,"state":51,"zip":442,"country":356,"countryCode":357,"cosmosGeoPoint":443,"geoPoint":447,"contacts":448},"Institut Gustave Roussy","Villejuif","94805",{"type":79,"coordinates":444},[445,446],2.35992,48.7939,{"lat":446,"lon":445},[449],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":451,"status":72,"city":452,"state":51,"zip":453,"country":454,"countryCode":455,"cosmosGeoPoint":51,"geoPoint":51,"contacts":51},"NHO Himeji Medical Center","Himeji-shi","670-8520","Japan","JP",{"facility":457,"status":72,"city":458,"state":51,"zip":459,"country":454,"countryCode":455,"cosmosGeoPoint":51,"geoPoint":51,"contacts":460},"Kansai Medical University Hospital","Hirakata-shi","573-1191",[461],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":463,"status":72,"city":464,"state":51,"zip":465,"country":454,"countryCode":455,"cosmosGeoPoint":466,"geoPoint":470,"contacts":471},"National Cancer Center Hospital East","Kashiwa","277-8577",{"type":79,"coordinates":467},[468,469],139.97732,35.86224,{"lat":469,"lon":468},[472],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":474,"status":72,"city":475,"state":51,"zip":476,"country":454,"countryCode":455,"cosmosGeoPoint":477,"geoPoint":481,"contacts":482},"The Cancer Institute Hospital of Jfcr","Kōtoku","135-8550",{"type":79,"coordinates":478},[479,480],143.14297,42.50417,{"lat":480,"lon":479},[483],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":485,"status":72,"city":486,"state":51,"zip":487,"country":454,"countryCode":455,"cosmosGeoPoint":488,"geoPoint":492,"contacts":493},"Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc. Saiseikai Kumamoto Hospital","Kumamoto","861-4193",{"type":79,"coordinates":489},[490,491],130.69181,32.80589,{"lat":491,"lon":490},[494],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":496,"status":72,"city":497,"state":51,"zip":498,"country":454,"countryCode":455,"cosmosGeoPoint":51,"geoPoint":51,"contacts":499},"Shizuoka Cancer Center","Nagaizumi-cho","411-8777",[500],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":502,"status":72,"city":503,"state":51,"zip":504,"country":454,"countryCode":455,"cosmosGeoPoint":505,"geoPoint":509,"contacts":510},"Niigata Cancer Center Hospital","Niigata","951-8566",{"type":79,"coordinates":506},[507,508],139.04125,37.92259,{"lat":508,"lon":507},[511],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":513,"status":72,"city":514,"state":51,"zip":515,"country":454,"countryCode":455,"cosmosGeoPoint":516,"geoPoint":520,"contacts":521},"Okayama University Hospital","Okayama","700-8558",{"type":79,"coordinates":517},[518,519],133.93333,34.65,{"lat":519,"lon":518},[522],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":524,"status":72,"city":525,"state":51,"zip":526,"country":454,"countryCode":455,"cosmosGeoPoint":527,"geoPoint":531,"contacts":532},"Kindai University Hospital","Ōsaka-sayama","589-8511",{"type":79,"coordinates":528},[529,530],135.55069,34.49524,{"lat":530,"lon":529},[533],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":535,"status":72,"city":536,"state":51,"zip":537,"country":454,"countryCode":455,"cosmosGeoPoint":538,"geoPoint":542,"contacts":51},"Tokushima University Hospital","Tokushima","770-8503",{"type":79,"coordinates":539},[540,541],134.56667,34.06667,{"lat":541,"lon":540},{"facility":544,"status":72,"city":545,"state":51,"zip":546,"country":454,"countryCode":455,"cosmosGeoPoint":51,"geoPoint":51,"contacts":51},"Fujita Health University Hospital","Toyoake-shi","470-1192",{"facility":548,"status":72,"city":549,"state":51,"zip":550,"country":551,"countryCode":552,"cosmosGeoPoint":553,"geoPoint":557,"contacts":558},"Hospital Clinic de Barcelona","Barcelona","08036","Spain","ES",{"type":79,"coordinates":554},[555,556],2.15899,41.38879,{"lat":556,"lon":555},[559],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":561,"status":72,"city":549,"state":51,"zip":562,"country":551,"countryCode":552,"cosmosGeoPoint":563,"geoPoint":565,"contacts":566},"Hospital Universitari Vall D'Hebron","8035",{"type":79,"coordinates":564},[555,556],{"lat":556,"lon":555},[567],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":569,"status":72,"city":570,"state":51,"zip":571,"country":551,"countryCode":552,"cosmosGeoPoint":572,"geoPoint":576,"contacts":577},"Ico Girona - Hospital Universitari de Girona Dr Josep Trueta","Girona","17007",{"type":79,"coordinates":573},[574,575],2.82493,41.98311,{"lat":575,"lon":574},[578],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":580,"status":72,"city":581,"state":51,"zip":582,"country":551,"countryCode":552,"cosmosGeoPoint":583,"geoPoint":587,"contacts":588},"ICO l'Hospitalet - Hospital Duran i Reynals","L'Hospitalet de Llobregat","08908",{"type":79,"coordinates":584},[585,586],2.10028,41.35967,{"lat":586,"lon":585},[589],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":591,"status":72,"city":592,"state":51,"zip":593,"country":551,"countryCode":552,"cosmosGeoPoint":594,"geoPoint":598,"contacts":599},"Hospital General Universitario Gregorio Marañon","Madrid","28007",{"type":79,"coordinates":595},[596,597],-3.70256,40.4165,{"lat":597,"lon":596},[600],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":602,"status":72,"city":592,"state":51,"zip":603,"country":551,"countryCode":552,"cosmosGeoPoint":604,"geoPoint":606,"contacts":607},"Hospital Universitario Ramon Y Cajal","28034",{"type":79,"coordinates":605},[596,597],{"lat":597,"lon":596},[608],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":610,"status":72,"city":592,"state":51,"zip":611,"country":551,"countryCode":552,"cosmosGeoPoint":612,"geoPoint":614,"contacts":615},"Hospital Universitario 12 de Octubre","28041",{"type":79,"coordinates":613},[596,597],{"lat":597,"lon":596},[616],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":618,"status":72,"city":592,"state":51,"zip":619,"country":551,"countryCode":552,"cosmosGeoPoint":620,"geoPoint":622,"contacts":623},"Next Madrid","28223",{"type":79,"coordinates":621},[596,597],{"lat":597,"lon":596},[624],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":626,"status":72,"city":627,"state":51,"zip":628,"country":551,"countryCode":552,"cosmosGeoPoint":629,"geoPoint":633,"contacts":634},"Hospital Regional Universitario de Malaga","Málaga","29010",{"type":79,"coordinates":630},[631,632],-4.42034,36.72016,{"lat":632,"lon":631},[635],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":637,"status":72,"city":638,"state":51,"zip":639,"country":551,"countryCode":552,"cosmosGeoPoint":640,"geoPoint":644,"contacts":645},"Hospital Universitario Virgen Macarena","Seville","41009",{"type":79,"coordinates":641},[642,643],-5.97317,37.38283,{"lat":643,"lon":642},[646],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":648,"status":72,"city":638,"state":51,"zip":649,"country":551,"countryCode":552,"cosmosGeoPoint":650,"geoPoint":652,"contacts":653},"Hospital Universitario Virgen Del Rocio","41013",{"type":79,"coordinates":651},[642,643],{"lat":643,"lon":642},[654],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"facility":656,"status":72,"city":657,"state":51,"zip":658,"country":551,"countryCode":552,"cosmosGeoPoint":659,"geoPoint":663,"contacts":664},"Hospital Alvaro Cunqueiro","Vigo","36312",{"type":79,"coordinates":660},[661,662],-8.72264,42.23282,{"lat":662,"lon":661},[665],{"name":86,"role":62,"phone":51,"phoneExt":51,"email":51},{"type":667,"investigatorFullName":51,"investigatorTitle":51,"investigatorAffiliation":51,"oldNameTitle":51,"oldOrganization":51},"SPONSOR",[669],{"name":670,"class":6},"Merck Sharp & Dohme LLC","100543928",false,"NCT06362252","A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)","A Phase 1b\u002F2, Multicenter, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody-Drug Conjugate (ADC), in Combination With Atezolizumab With or Without Carboplatin as First-line Induction or Maintenance, in Subjects With Extensive-stage Small Cell Lung Cancer (ES-SCLC) (IDeate-Lung03)","A full list of inclusion\u002Fexclusion criteria are available in the protocol.\n\nInclusion Criteria\n\nParticipants must meet all of the following criteria to be eligible for enrollment into the study:\n\n1. Sign and date the informed consent form (ICF), prior to the start of any study-specific qualification procedures.\n2. Adults ≥18 years or the minimum legal adult age (whichever is greater) at the time the ICF is signed.\n3. Has histologically or cytologically confirmed diagnosis of ES-SCLC who will require first-line (IL) therapy.\n4. For Cohort 1, participant has received 4 cycles of 1L induction therapy with carboplatin, etoposide, and atezolizumab for ES-SCLC with ongoing CR PR, CR, or SD per RECIST v1.1 assessed by the investigator.\n\n   For Cohort 2, participant has received no prior treatment for ES-SCLC.\n5. For Cohort 2, participant has at least one measurable lesion according to RECIST v1.1 on computed tomography (CT) or magnetic resonance imaging (MRI) as assessed by the investigator.\n6. For Cohort 2, participant must have at least one lesion, amenable to core biopsy, and must consent to provide a pretreatment biopsy tissue sample and on-treatment biopsy.\n7. Has ECOG PS of ≤1 (assessed within 7 days before enrollment\u002Frandomization).\n8. Has adequate organ and bone marrow function within 7 days before the start of study treatment as specified in the study protocol.\n9. A female subject of childbearing potential (POCBP) is eligible to participate if the following conditions are met:\n\n   1. Subject is not pregnant as confirmed by highly sensitive pregnancy test during Screening (within 3 days prior to enrollment\u002Frandomization)\n   2. Subject does not breastfeed during the treatment period and for at least 8\u002F5\u002F6 months after last dose of I-DXd\u002Fatezolizumab\u002Fcarboplatin, respectively.\n   3. Subject agrees to adhere to a contraceptive method that is highly effective and agrees not to donate eggs (ova, oocytes) to others or freeze\u002Fstore eggs during the treatment period and for at least the time needed to eliminate each study drug after the last dose. The length of time required to continue contraception and avoid donating\u002Ffreezing eggs after last dose for I-DXd\u002Fatezolizumab\u002Fcarboplatin is 8\u002F5\u002F6 months, respectively. Preservation of eggs may be considered prior to first dose of study drug.\n10. A male subject capable of producing sperm is eligible to participate if he agrees to the following during the intervention period and for at least the time needed to eliminate each study drug. The length of time required to continue contraception and avoid donating sperm after last dose for I-DXd\u002Fatezolizumab\u002Fcarboplatin is 6\u002F5\u002F6 months, respectively.\n\n    1. Avoid donating sperm.\n    2. Adhere to either of the contraception methods: true abstinence from penile-vaginal intercourse or uses a penile\u002Fexternal condom when having penile-vaginal intercourse with a non-subject of childbearing potential plus partner use of an additional contraceptive method.\n11. Is willing and able to comply with scheduled visits, drug administration plan, laboratory tests, other study procedures, and study restrictions.\n\nExclusion Criteria\n\nParticipants who meet any of the following criteria will be disqualified from entering the study:\n\n1. Has received prior treatment with orlotamab, enoblituzumab, or other B7-H3 targeted agents, including I-DXd.\n2. Prior discontinuation of an ADC that consists of an exatecan derivative (eg, trastuzumab deruxtecan) due to treatment-related toxicities.\n3. Has received prior treatment with CD137 agonists or ICIs, including anti-cytotoxic T-cell lymphocyte-4, anti-PD-1, and anti-PD-L1 therapeutic antibodies, except for atezolizumab for Cohort 1.\n4. Has inadequate washout period before enrollment\u002Frandomization as specified in the study protocol.\n5. Has any of the following within the past 6 months: cerebrovascular accident, transient ischemic attack, or another arterial thromboembolic event.\n6. Has clinically active brain metastases, spinal cord compression, or leptomeningeal carcinomatosis, defined as untreated and symptomatic, or requiring therapy with steroids or anticonvulsants to control associated symptoms.\n7. Has clinically significant corneal disease.\n8. Has uncontrolled or significant cardiovascular disease,.\n9. Has history of (non-infectious) ILD\u002Fpneumonitis that required corticosteroids, current ILD\u002Fpneumonitis, or suspected ILD\u002Fpneumonitis that cannot be ruled out by imaging at Screening.\n10. Has clinically severe pulmonary compromise resulting from intercurrent pulmonary illnesses\n11. Is on chronic steroid treatment (dose of 10 mg daily or more prednisone equivalent), except for low-dose inhaled steroids (for asthma\u002Fchronic obstructive pulmonary disease, topical steroids (for mild skin conditions), or intra-articular steroid injections.\n12. Has history of malignancy other than SCLC within the 5 years prior to randomization\u002Fenrollment, except adequately resected non-melanoma skin cancer, curatively treated in situ disease, superficial gastrointestinal tract tumors, and non-muscle invasive bladder cancer curatively resected by endoscopic surgery.\n13. Has history of allogeneic bone marrow, stem cell, or solid organ transplant.\n14. Has unresolved toxicities from previous anticancer therapy, defined as toxicities (other than alopecia) not yet resolved to NCI-CTCAE V5.0, Grade ≤1 or baseline.\n15. Has history of hypersensitivity to the drug substances, inactive ingredients in the drug product or severe hypersensitivity reactions to other monoclonal antibodies.\n16. Has evidence of ongoing uncontrolled systemic bacterial, fungal, or viral infection.\n17. Has active or uncontrolled human immunodeficiency virus (HIV) infection.\n18. Has active or uncontrolled hepatitis B or C virus (HBV or HCV) infection.\n19. Has history of autoimmune disease.\n20. Has any evidence of severe or uncontrolled systemic diseases.\n21. Has received a live vaccine within 30 days prior to the first dose of study drug.\n22. Is a female who is pregnant or breastfeeding or planning to become pregnant.\n23. Has prior or ongoing clinically relevant illness, medical condition, surgical history, physical finding, or laboratory abnormality that, in the investigator's opinion, could affect the safety of the participant; alter the absorption, distribution, metabolism, or excretion of the study drug; or confound the assessment of study results.\n24. Has psychological, social, familial, or logistical factors that would prevent regular follow-up","ALL","18 Years",{"count":680,"type":681},123,"ESTIMATED","INTERVENTIONAL",[684,685],"PHASE1","PHASE2","This study is designed to evaluate the safety and efficacy of ifinatamab deruxtecan (I-DXd) in combination with immune checkpoint inhibitor (ICI) atezolizumab with or without carboplatin in participants with extensive stage-small cell lung cancer (ES-SCLC) in the first-line (1L) setting.",[688],"Extensive Stage-small Cell Lung Cancer",[690,43,47],"Extensive stage-small cell lung cancer (ES-SCLC)","2026-02-04",{"date":693,"type":694},"2026-02-06","ACTUAL",{"date":696,"type":694},"2024-07-22",{"date":698,"type":681},"2026-12-30",{"name":5,"class":6},58]